Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor.
about
Biological and Pharmacological Aspects of the NK1-ReceptorSubstance P induces rapid and transient membrane blebbing in U373MG cells in a p21-activated kinase-dependent mannerNeurogenic inflammation after traumatic brain injury and its potentiation of classical inflammationSubstance P is a mechanoresponsive, autocrine regulator of human tenocyte proliferationA randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adultsNeurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho/Rho-associated coiled-coil kinase-dependent mechanism.HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance PTruncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.Neurokinin-1 receptor antagonist treatment in polymicrobial sepsis: molecular insightsSubstance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.Neurokinin 1 receptor mediates membrane blebbing and sheer stress-induced microparticle formation in HEK293 cellsRe-Evaluation of the PBAN Receptor Molecule: Characterization of PBANR Variants Expressed in the Pheromone Glands of Moths.Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.An involvement of neurokinin-1 receptor in FcεRΙ-mediated RBL-2H3 mast cell activation.Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor.Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R)The Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain.Transforming Growth Factor Beta 1 Modulates the Functional Expression of the Neurokinin-1 Receptor in Human Keratocytes.Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management.Activation of neurokinin-1 receptors up-regulates substance P and neurokinin-1 receptor expression in murine pancreatic acinar cells.Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathologyAnalog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor.Endosomal endothelin-converting enzyme-1: a regulator of beta-arrestin-dependent ERK signaling.The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS DisordersTachykinins and their receptors: contributions to physiological control and the mechanisms of disease.Targeting tachykinin receptors in neuroblastoma.Tachykinins and Neurokinin Receptors in Bone Marrow Functions: Neural-Hematopoietic Link.Neuropeptide substance P and the immune response.Substance P Regulation in Epilepsy.Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.Substance P-mediated chemokine production promotes monocyte migration.Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P.Continuous infusion of substance P into rat striatum alleviates nociceptive behavior via phosphorylation of extracellular signal-regulated kinase 1/2.Truncation of neurokinin-1 receptor-Negative regulation of substance P signaling.Substance P modulates bone remodeling properties of murine osteoblasts and osteoclasts.
P2860
Q26784074-3505591D-926A-4E54-84EC-692280B71E51Q27318383-77DDF9AD-5B72-4F7C-ADC5-B7A33D675719Q28069959-CD966D86-28C0-4072-9591-25A20B4948E0Q28393264-E100982F-80C4-4BF7-94B2-ACBA0CD13FADQ28740565-FAE85FF0-1BC0-4491-9750-5A821A69C867Q30486884-8E1950A7-4783-4F9C-818A-3DFB998D9291Q33750864-AAD930C3-308F-4771-9E95-90AB00366ABAQ34039324-FA74AF1E-E800-409F-9B99-7A7AEA7DAC83Q34150798-E6B29EA4-D031-4D12-98A1-C9C41E1363A3Q34415133-2649A3B6-C7D6-4520-89D6-DDBEA20A933BQ34417546-5ED096B6-B9B3-489D-9EBD-EE6BBD8F7125Q34425335-E4FCD89B-8C92-4B4E-B402-9FF5A281ED6BQ35972045-2EC475BC-6652-4BD7-B817-367FD860755EQ36043712-D3BE419D-07AA-45BD-9334-EECF9AECD0E3Q36319631-2EA588D1-712A-43ED-BC53-5EDBB49B56D1Q37034775-6ACF81BB-29FE-4298-91DE-827371FD7E82Q37062163-ADBDA606-F241-46B4-B307-6DEC4B2B4ADEQ37149019-B883D6B9-1577-44BD-89FA-5CBA0E36A7ABQ37186647-FCE21AE5-2368-4626-B116-C4448281DE93Q37258385-44836408-48AF-489C-8BDB-CDA88787FE12Q37295550-EA0BBF9E-F784-4C26-935B-09752A558810Q37302953-07C197C4-F519-4ADD-9016-36B5414D56F7Q37340453-D6A8D6B2-6362-4146-9206-F065061C00CCQ37372302-C6951653-ECF9-4391-B9AD-09622BB5D13CQ37553389-92442BB1-BCA4-43A0-87AE-732245BFD89CQ37593097-C78FD6CA-E248-412F-8BD1-C58F004DC388Q37702248-F17188B6-F573-4268-BCE9-6631D791A97BQ37769121-CCAFE5EF-B02B-4CDF-BC2A-9734AE9287B2Q38868323-3EE1A754-3E3F-480F-ACC6-CAB6677224AFQ39285392-550949D7-EE59-400E-BFD1-8F794D75AF7DQ40085168-B41E07F5-917B-461E-B608-76D53A8C414FQ40268840-3B2896D9-7DF0-46AA-B43C-F182A707C5CBQ47119077-E174582E-84F4-4ECC-9B2E-ABF7BC63FCF8Q48572411-E1CDA9D2-FC1A-4BFA-AE5F-ACDF77F210A1Q49972918-3611FD23-E97C-4705-93F3-F8E674F63F35Q55313392-AA2D214A-9717-439A-AF60-B888DBE119F5
P2860
Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Differences in the length of t ...... ties of neurokinin-1 receptor.
@en
type
label
Differences in the length of t ...... ties of neurokinin-1 receptor.
@en
prefLabel
Differences in the length of t ...... ties of neurokinin-1 receptor.
@en
P2093
P2860
P356
P1476
Differences in the length of t ...... ties of neurokinin-1 receptor.
@en
P2093
Florin Tuluc
Jian-Ping Lai
Laurie E Kilpatrick
Morris F Tansky
Steven D Douglas
P2860
P304
12605-12610
P356
10.1073/PNAS.0806632105
P407
P577
2008-08-19T00:00:00Z